![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, January 25, 2013 7:56:19 PM
Above all I owe an apology to Dr Menon. I regret and fully retract my previous posts concerning Dr Menon.
I believe now I was so very wrong. -eddiebali
Thank you for rejoining the board and setting the record straight. That is Due Diligence at its finest and shows the value of open discussion.
I have bought ctix shares and will continue to buy. -eddiebali
We can't predict the future but so far there have been very few days one could have bought CTIX and not already been in profit. There is always risk, but there is also great potential here.
I am delighted to be a ctix shareholder.
I would like to thank many on this board for their incredible thorough DD.
While on my recent holiday I have studied ctix a lot more. Ive got that excited feeling that maybe just maybe................ -eddiebali
Cellceutix is a very unique company.
I can't find a single other example of a biotech company so well positioned in terms of share structure and financing going into clinical trials. Most require heavy dilution, yet the fantastic terms of the Aspire Capital financing, the owners deferring salary and providing financing, and the wonderful, cost saving arrangements with leading cancer research hospitals give CTIX shareholders great protection.
These world renown research hospitals and universities don't act recklessly with their resources, there is something about Kevetrin that has really focused their attention.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM